logo
Plus   Neg
Share
Email

AstraZeneca Prices $3 Bln Bond Offering

AstraZeneca Plc. (AZN.L,AZN) said Tuesday that it priced a three tranche global bond offering totalling $3 billion. It expects to close the offering on 6 August 2020.

The company expects to use the net proceeds of the issue for general corporate purposes, which may include the refinancing of existing indebtedness.

The transaction consists of the following three tranches: $1.2 billion of fixed rate notes with a coupon of 0.700%, maturing 8 April 2026; $1.3 billion of fixed rate notes with a coupon of 1.375%, maturing 6 August 2030; and $0.5 billion of fixed rate notes with a coupon of 2.125%, maturing 6 August 2050.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT